Express Scripts Holding Company (ESRX) was Resumed by BofA/Merrill to “Neutral”. BofA/Merrill advised their investors in a research report released on Jun 7, 2016.
Many Wall Street Analysts have commented on Express Scripts Holding Company. Shares were Reiterated by FBR Capital on Apr 27, 2016 to “Mkt Perform” and Lowered the Price Target to $ 75 from a previous price target of $90 .Express Scripts Holding Company was Initiated by Credit Suisse to “Outperform” on Mar 16, 2016.
On the company’s financial health, Express Scripts Holding Company reported $1.22 EPS for the quarter, based on the information available during the earnings call on Apr 25, 2016. Analyst had a consensus estimate of $1.22. The company had revenue of $24792.00 million for the quarter, compared to analysts expectations of $25135.07 million. The company’s revenue was down -.4 % compared to the same quarter last year.During the same quarter in the previous year, the company posted $1.10 EPS.
Express Scripts Holding Company closed down -0.65 points or -0.85% at $75.61 with 28,10,514 shares getting traded on Friday. Post opening the session at $76.17, the shares hit an intraday low of $74.95 and an intraday high of $76.23 and the price fluctuated in this range throughout the day.Shares ended Friday session in Red.
In a different news, on May 11, 2016, Everett Neville (Senior VP, Supply Chain) sold 800 shares at $74.11 per share price. According to the SEC, on May 3, 2016, Mahon Thomas P Mac (director) sold 5,482 shares at $73.93 per share price. On Mar 11, 2016, Christopher A Mcginnis (VP, Controller & Ch. Acct. Off) sold 579 shares at $68.56 per share price, according to the Form-4 filing with the securities and exchange commission.